Clinical Trials Directory

Trials / Completed

CompletedNCT04266691

Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung Cancer

Molecular Metastasis in Lymph Nodes is Associated With Survival of Patients With Stage I NSCLC

Status
Completed
Phase
Study type
Observational
Enrollment
237 (actual)
Sponsor
Zhejiang Cancer Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Analysis of driver gene variation in early stage non-small cell lung cancer

Detailed description

Fluorescence quantitative polymerase chain reaction (PCR) was used to detect the variation of driver gene in regional lymph nodes of early stage non-small cell lung cancer (NSCLC), and to analyze the relationship between the variation and disease recurrence and survival prognosis. evaluate the effect of the variation of driving gene in lymph nodes of early stage NSCLC on prognosis, identify the high-risk factors that promote the recurrence and metastasis of early stage tumor. so as to improve the diagnosis and treatment path of lung cancer, provide important pathological basis for the clinical diagnosis and treatment of early stage non-small cell lung cancer, enable patients to receive more accurate treatment, and improve their survival prognosis.

Conditions

Interventions

TypeNameDescription
OTHERnonInterventionnonIntervention

Timeline

Start date
2009-01-01
Primary completion
2015-12-01
Completion
2019-06-01
First posted
2020-02-12
Last updated
2020-02-12

Source: ClinicalTrials.gov record NCT04266691. Inclusion in this directory is not an endorsement.